- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Strides Pharma Science Ltd is in the business of development and manufacturing of pharmaceutical products.The company's pharmaceutical products are sold in over 100 countries.The company has always followed an inorganic growth strategy over the years that resulted in foray into new markets, addition of new business segments, therapy segments and manufacturing infrastructure.
Strides Pharma Science reported Q1 FY27 revenue up 13% YoY, with Ex-US revenue at ₹587.5 Cr ($63 Mn), growing 17% YoY despite temporary shipment delays. US revenue stood at ₹628.2 Cr ($68 Mn). EBITDA was ₹229.8 Cr (18.2% margin), up 5.4% YoY, absorbing ₹13.1 Cr in geopolitical-related costs. Reported PAT...